SBI Securities Co. Ltd. reduced its position in Tilray Brands, Inc. (NASDAQ:TLRY – Free Report) by 89.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 28,236 shares of the company’s stock after selling 234,859 shares during the quarter. SBI Securities Co. Ltd.’s holdings in Tilray Brands were worth $255,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of TLRY. AQR Capital Management LLC boosted its stake in shares of Tilray Brands by 1,839.7% in the 1st quarter. AQR Capital Management LLC now owns 607,054 shares of the company’s stock valued at $399,000 after purchasing an additional 575,757 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Tilray Brands during the 2nd quarter valued at $112,000. Cerity Partners LLC lifted its position in shares of Tilray Brands by 98.5% during the 2nd quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock valued at $38,000 after acquiring an additional 45,929 shares during the period. Ausdal Financial Partners Inc. acquired a new position in shares of Tilray Brands during the 2nd quarter valued at $939,000. Finally, Bank of America Corp DE lifted its position in shares of Tilray Brands by 26.5% during the 2nd quarter. Bank of America Corp DE now owns 311,810 shares of the company’s stock valued at $129,000 after acquiring an additional 65,379 shares during the period. 9.35% of the stock is owned by institutional investors.
Tilray Brands Stock Down 1.8%
Tilray Brands stock opened at $5.56 on Friday. The company has a quick ratio of 1.66, a current ratio of 2.79 and a debt-to-equity ratio of 0.19. The firm’s fifty day moving average is $6.80 and its 200 day moving average is $8.80. Tilray Brands, Inc. has a 12-month low of $3.51 and a 12-month high of $23.20. The company has a market capitalization of $648.02 million, a PE ratio of -0.41 and a beta of 1.94.
Insiders Place Their Bets
In other Tilray Brands news, Director David G. Hopkinson sold 33,556 shares of the company’s stock in a transaction on Tuesday, April 21st. The shares were sold at an average price of $6.94, for a total transaction of $232,878.64. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.84% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts recently issued reports on the stock. Zacks Research upgraded shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, February 11th. Weiss Ratings upgraded shares of Tilray Brands from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, April 29th. ATB Cormark Capital Markets dropped their target price on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 2nd. Roth Mkm upgraded shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Thursday, April 2nd. Finally, Wall Street Zen upgraded shares of Tilray Brands from a “sell” rating to a “hold” rating in a research report on Saturday, March 21st. Three equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $11.50.
Get Our Latest Stock Report on TLRY
Tilray Brands Company Profile
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Featured Stories
- Five stocks we like better than Tilray Brands
- Buffett Spent 60 Years Ignoring Tech and the Bill Is Coming Due
- Excited About Gold But Unsure of Its Trajectory? Try These 3 Approaches
- Dollar at a 3-Year Low: 3 Exporters Quietly Printing Money
- Water Infrastructure: Why This Boring Sector Could Get Exciting
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Brands, Inc. (NASDAQ:TLRY – Free Report).
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
